Thrombosis Research, 1879-2472

Tidskrift

Fler filtreringsmöjligheter
  1. Artikel i vetenskaplig tidskrift
  2. Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A: Interim analysis from the LEOPOLD Kids extension study

    Gili Kenet, Rolf Ljung, Luminita Rusen, Bryce A Kerlin, Victor Blanchette, Sonata Saulytė Trakymienė, Valentina Uscatescu, Horst Beckmann, Despina Tseneklidou-Stoeter & Nikki Church, 2020 maj, I: Thrombosis Research. 189, s. 96-101 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillation

    M. Jansson, S. Själander, V. Sjögren, H. Renlund, B. Norrving & A. Själander, 2020, I: Thrombosis Research. 185, s. 135-141 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. The role of von Willebrand factor in acute type A aortic dissection and aortic surgery

    Igor Zindovic, Johan Sjögren, Henrik Bjursten, Richard Ingemansson, Mårten Larsson, Peter J. Svensson, Karin Strandberg, Per Wierup & Shahab Nozohoor, 2019, I: Thrombosis Research. 178, s. 139-144 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Hypertension and cardiovascular diseases in Swedish persons with haemophilia — A longitudinal registry study

    Susanna Lövdahl, Karin M. Henriksson, Fariba Baghaei, Margareta Holmström, Erik Berntorp & Jan Astermark, 2019, I: Thrombosis Research. 181, Sept., s. 106-111

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation

    Sara Själander, Vilhelm Sjögren, Henrik Renlund, Bo Norrving & Anders Själander, 2018 jul 1, I: Thrombosis Research. 167, s. 113-118 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Increased platelet activation occurs in cystic fibrosis patients and correlates to clinical status

    Ulrika Lindberg, Lisbeth Svensson, Thomas Hellmark, Mårten Segelmark & Oonagh Shannon, 2018 feb 1, I: Thrombosis Research. 162, s. 32-37

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients

    Line Hjellström & Ashkan Labaf, 2018, I: Thrombosis Research. 163, s. 180-184

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs)

    Simona Grasso, Ariane Neumann, Irene M. Lang, Michael Etscheid, Maren von Köckritz-Blickwede & Sandip M. Kanse, 2018, I: Thrombosis Research. 161, s. 36-42 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention

    Dimitrios Venetsanos, Tomas L. Lindahl, Sofia Sederholm Lawesson, Kerstin M. Gustafsson, Håkan Wallen, David Erlinge, Eva Swahn & Joakim Alfredsson, 2018, I: Thrombosis Research. 171, s. 38-44 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Ischemic stroke rates decline in patients with atrial fibrillation as anticoagulants uptake improves: A Swedish cohort study

    Natalia Mochalina, Nazim Isma, Peter J. Svensson, Anders Själander, Maj Carlsson, Tord Juhlin & Mattias Wieloch, 2017 okt 1, I: Thrombosis Research. 158, s. 44-48 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Comparison of citrated and fresh whole blood for viscoelastic coagulation testing during elective neurosurgery

    E. Silverberg, F. Tornqvist, T. Kander, J. Bengzon, Gemma C. Solomon, J. Bonnevier & U. Schött, 2017 aug 1, I: Thrombosis Research. 156, s. 73-79 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden

    A. Schönning, J. Karlén, T Frisk, M M Heyman, J. E. Svahn, I. Øra, L. Kawan, B. M. Holmqvist, C. Björklund, Arja Harila-Saari & S Ranta, 2017 apr 1, I: Thrombosis Research. 152, s. 64-68 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. A sibling based design to quantify genetic and shared environmental effects of venous thromboembolism in Sweden

    Bengt Zöller, Henrik Ohlsson, Jan Sundquist & Kristina Sundquist, 2017 jan, I: Thrombosis Research. 149, s. 82-87

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Current view and outcome of ITI therapy: A change over time?

    K. Holstein, A. Batorova, M. Carvalho, K. Fijnvandraat, P. Holme, K. Kavakli, T. Lambert, A. Rocino, V. Jiménez-Yuste & J. Astermark, 2016 dec, I: Thrombosis Research. 148, s. 38-44

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: A population-based cohort study.

    Natalia Mochalina, Anna Jöud, Maj Carlsson, Maria Sandberg, Anders Själander, Tord Juhlin & Peter Svensson, 2016, I: Thrombosis Research. 140, s. 94-99

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Warfarin persistence among stroke patients with atrial fibrillation.

    Fredrik Björck, Henrik Renlund, Peter Svensson & Anders Själander, 2015, I: Thrombosis Research. 136, 4, s. 744-748

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden.

    Fredrik Björck, Per Sandén, Henrik Renlund, Peter Svensson & Anders Själander, 2015, I: Thrombosis Research. 136, 2, s. 216-220

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.

    Oscar Braun, Besim Bico, Uzma Chaudhry, Henrik Wagner, Sasha Koul, Patrik Tydén, Fredrik Scherstén, Stefan Jovinge, Peter Svensson, Gustav Smith & Jesper vanderPals, 2015, I: Thrombosis Research. 135, 1, s. 26-30

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Warfarin treatment complications do not correlate to cTTR when above 70.

    Per Sandén, Henrik Renlund, Peter Svensson & Anders Själander, 2015, I: Thrombosis Research. 136, 6, s. 1185-1189

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. INR variability and outcomes in patients with mechanical heart valve prosthesis.

    Ashkan Labaf, Anders Själander, Martin Stagmo & Peter Svensson, 2015, I: Thrombosis Research. 136, 6, s. 1211-1215

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Comparison of automated von Willebrand factor activity assays.

    Annette Timm, Andreas Hillarp, Malou Philips & Jens P Goetze, 2015, I: Thrombosis Research.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. A comprehensive study of ovine haemostasis to assess suitability to model human coagulation

    Samuel R Foley, Connie Solano, Gabriela Simonova, Michelle M Spanevello, Robert J Bird, John W Semple, Denise E Jackson, Andreas Schibler, John F Fraser & Yoke Lin Fung, 2014 aug, I: Thrombosis Research. 134, 2, s. 468-73 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.

    Sofia Somajo, Ruzica Livaja Koshiar, Eva Norström & Björn Dahlbäck, 2014, I: Thrombosis Research. 134, 1, s. 144-152

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.

    Roza Chaireti, Rupesh Rajani, Annika Bergquist, Tor Melin, Inga-Lill Friis-Liby, Marjo Kapraali, Stergios Kechagias, Tomas L Lindahl & Sven Almer, 2014, I: Thrombosis Research. 134, 2, s. 455-461

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study.

    Joseph A Jakubowski, Dominick J Angiolillo, Chunmei Zhou, David S Small, Brian A Moser, Jurrien M Ten Berg, Patricia B Brown, Stefan James, Kenneth J Winters & David Erlinge, 2014, I: Thrombosis Research. 134, 3, s. 552-557

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Thromboembolism, major bleeding and mortality in patients with mechanical heart valves- a population-based cohort study.

    Ashkan Labaf, Bartosz Grzymala-Lubanski, Martin Stagmo, Susanna Lövdahl, Mattias Wieloch, Anders Själander & Peter Svensson, 2014, I: Thrombosis Research. 134, 2, s. 354-359

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Glycosaminoglycans in cancer treatment.

    Mattias Belting, 2014, I: Thrombosis Research. 133, s. S95-S101

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Outcome after thrombolysis for occluded endoprosthesis, bypasses and native arteries in patients with lower limb ischemia.

    Monica Kuoppala, Jonas Åkeson & Stefan Acosta, 2014, I: Thrombosis Research. 134, 1, s. 23-28

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Mechanical heart valve prosthesis and warfarin - Treatment quality and prognosis.

    Bartosz Grzymala-Lubanski, Ashkan Labaf, Erling Englund, Peter Svensson & Anders Själander, 2014, I: Thrombosis Research. 133, 5, s. 795-798

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.

    Mattias Wieloch, Karl Jönsson, Anders Själander, Gregory Y H Lip, Niclas Eriksson & Peter J Svensson, 2013, I: Thrombosis Research. 131, 6, s. 481-486

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses

    Bartosz Grzymala-Lubanski, Sara Sjalander, Henrik Renlund, Peter Svensson & Anders Sjalander, 2013, I: Thrombosis Research. 131, 2, s. 130-134

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. The APC-PCI concentration as an early marker of activation of blood coagulation A study of women on combined oral contraceptives

    K. Bremme, R. Rafik Hamad, Elisabeth Berg, Karin Strandberg & Johan Stenflo, 2012, I: Thrombosis Research. 130, 4, s. 636-639

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.

    Signy Sveinsdottir, Ymir Saemundsson, Nazim Isma, Anders Gottsäter & Peter Svensson, 2012, I: Thrombosis Research. 130, 3, s. 467-471

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. The value of tomographic ventilation/perfusion scintigraphy (V/PSPECT) for follow-up and prediction of recurrence in pulmonary embolism.

    Alaa Alhadad, Massimo Miniati, Hussein Alhadad, Anders Gottsäter & Marika Bajc, 2012, I: Thrombosis Research.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Immune tolerance induction in patients with hemophilia A

    Jan Astermark, 2011, I: Thrombosis Research. 127, s. S6-S9

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy

    Gregory Y. H. Lip, Lars H. Rasmussen, Bertil Olsson, Sofia Zetterstrand, Christina Stahre, Anders Bylock, Maria Aunes-Jansson, Ulf Eriksson & Karin Wahlander, 2011, I: Thrombosis Research. 127, 2, s. 91-99

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD

    G. Castaman, A. Tosetto, A. Cappelletti, A. Goodeve, A. B. Federici, J. Batlle, D. Meyer, J. Goudemand, J. C. J. Eikenboom, R. Schneppenheim, U. Budde, J. Ingerslev, Stefan Lethagen, F. Hill, I. R. Peake & F. Rodeghiero, 2010, I: Thrombosis Research. 126, 3, s. 227-231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Treatment of the critically ill patient with protein C: Is it worth the cost?

    Gunnar Nilsson, Sören Höjgård & Erik Berntorp, 2010, I: Thrombosis Research. 125, 6, s. 494-500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. History of rFVIIa therapy.

    Ulla Hedner, 2010, I: Thrombosis Research. 125 Suppl 1, s. S4-S6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Coagulation activation and ultrasound characteristics in patients with carotid artery disease.

    Tilo Kölbel, Isabel Goncalves, Nuno Dias, Karin Strandberg, Stefan Acosta & Anders Gottsäter, 2010, I: Thrombosis Research. 125, s. 171-177

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Anti-prothrombin antibodies are associated with thrombosis in children.

    Olof Rask, Andreas Hillarp, Erik Berntorp & Rolf Ljung, 2010, I: Thrombosis Research. 125, s. 19-24

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 Nästa